Phase I study of BMS-599626, an oral pan-HER tyrosine kinase inhibitor, in patients with advanced solid tumors
2005 ◽
Vol 23
(16_suppl)
◽
pp. 3152-3152
◽
Keyword(s):
Phase I
◽
2011 ◽
Vol 18
(4)
◽
pp. 1092-1100
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 3016-3016
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 2530-2530
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 3098-3098
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 2530-2530
◽
2008 ◽
Vol 14
(7)
◽
pp. 2075-2081
◽